Alessandro Armuzzi

Also affiliated with IRCCS Humanitas Research Hospital

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease”.

Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease

Gastroenterology(2020)10.1053/j.gastro.2020.01.047

N/A

5.9DataRank · unranked

318 citations

Brian G. Feagan, Edward V. Loftus, Laurent Peyrin‐Biroulet, Gert Van Assche, Geert D’Haens +17 more

Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease

Gastroenterology(2020)10.1053/j.gastro.2020.03.039

N/A

5.7DataRank · unranked

240 citations

Clara Yzet, Peter Bossuyt, Filip J. Baert, Thomas Vanasek, Geert D’Haens +34 more

Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn’s Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies

Journal of Crohn s and Colitis(2024)10.1093/ecco-jcc/jjae164

N/A

0.303DataRank · unranked

5 citations

Marc Ferrante, Remo Panaccione, Brian G. Feagan, О. Б. Щукина, Vipul Jairath +11 more

Sa1750 - The Effect of Tofacitinib on Serum Lipids and Cardiovascular Safety in Patients with Ulcerative Colitis - Results from the Tofacitinib Ulcerative Colitis Clinical Program

Gastroenterology(2018)10.1016/s0016-5085(18)31574-9

N/A

0.104DataRank · unranked

1 citations

Pam R. Taub, Brian G. Feagan, Alessandro Armuzzi, Gary S. Friedman, Michele Moscariello +8 more

Novel Insights Into the Interactions Between the Gut Microbiome, Inflammasomes, and Gasdermins During Colorectal Cancer

Frontiers in Cellular and Infection Microbiology(2022)10.3389/fcimb.2021.806680

N/A

0DataRank · unranked

28 citations

Nitish Rana, Franco Scaldaferri, Alessandro Armuzzi, Theresa T. Pizarro, Giuseppe Privitera

Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis

Clinical Gastroenterology and Hepatology(2022)10.1016/j.cgh.2022.07.032

N/A

0DataRank · unranked

106 citations

Antonio Facciorusso, Tine Jess, Christopher Ma, Cesare Hassan, Alessandro Repici +4 more

The gasdermin protein family: emerging roles in gastrointestinal health and disease

Nature Reviews Gastroenterology & Hepatology(2023)10.1038/s41575-023-00743-w

N/A

0DataRank · unranked

71 citations

Nitish Rana, Alessandro Armuzzi, Theresa T. Pizarro, Giuseppe Privitera